(Q35514544)

8 August 2017

1 reference

title

Scar wars strategies. Target collagen (English)

1 reference

8 August 2017

Low SQ

1

1 reference

8 August 2017

Moy RL

series ordinal

2

1 reference

8 August 2017

publication date

1 November 1992

1 reference

The Journal of dermatologic surgery and oncology

8 August 2017

published in

1 reference

8 August 2017

volume

18

1 reference

8 August 2017

issue

11

1 reference

8 August 2017

page(s)

981-986

1 reference

Inhibition of collagen accumulation in fibrotic processes: review of pharmacologic agents and new approaches with amino acids and their analogues

8 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4725.1992.TB02770.X

Proline analogues inhibit human skin fibroblast growth and collagen production in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4725.1992.TB02770.X

Inhibition of Liver Fibrosis by L-Azetidine-2-Carboxylic Acid in Rats Treated with Carbon Tetrachloride

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4725.1992.TB02770.X

Native cross-links in collagen fibrils induce resistance to human synovial collagenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4725.1992.TB02770.X

Pentoxifylline inhibits normal human dermal fibroblast in vitro proliferation, collagen, glycosaminoglycan, and fibronectin production, and increases collagenase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4725.1992.TB02770.X

Pentoxifylline inhibits the proliferation of human fibroblasts derived from keloid, scleroderma and morphoea skin and their production of collagen, glycosaminoglycans and fibronectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4725.1992.TB02770.X

The human interferon-gamma receptor system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4725.1992.TB02770.X

Selective inhibition of human diploid fibroblast collagen synthesis by interferons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4725.1992.TB02770.X

Gamma interferon is the lymphokine and beta interferon the monokine responsible for inhibition of fibroblast collagen production and late but not early fibroblast proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4725.1992.TB02770.X

Differential regulation of glycosaminoglycan, fibronectin, and collagenase production in cultured human dermal fibroblasts by interferon-alpha, -beta, and -gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4725.1992.TB02770.X

Persistence of a reduced-collagen-producing phenotype in cultured scleroderma fibroblasts after short-term exposure to interferons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4725.1992.TB02770.X

Gamma-interferon inhibits collagen synthesis in vivo in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4725.1992.TB02770.X

Recombinant interferon-gamma in the treatment of systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4725.1992.TB02770.X

Intralesional interferon gamma treatment for keloids and hypertrophic scars

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4725.1992.TB02770.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4725.1992.TB02770.X

Treatment of Ph+ chronic myeloid leukemia by gamma interferon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4725.1992.TB02770.X

Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4725.1992.TB02770.X

In vitro and in vivo association of transforming growth factor-beta 1 with hepatic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4725.1992.TB02770.X

Expression and secretion of type beta transforming growth factor by activated human macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4725.1992.TB02770.X

Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4725.1992.TB02770.X

Some recent advances in the chemistry and biology of transforming growth factor-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4725.1992.TB02770.X

Soluble cytokine receptors are present in normal human urine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4725.1992.TB02770.X

Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4725.1992.TB02770.X

Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4725.1992.TB02770.X

Membrane-anchored and soluble forms of betaglycan, a polymorphic proteoglycan that binds transforming growth factor-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4725.1992.TB02770.X

Interleukin 2 receptors are released by cells in vitro and in vivo. I. Detection of soluble IL 2 receptors in cell culture supernatants and in the serum of mice by an immunoradiometric assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4725.1992.TB02770.X

The murine interleukin-4 receptor: molecular cloning and characterization of secreted and membrane bound forms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4725.1992.TB02770.X

Molecular cloning and expression of a receptor for human tumor necrosis factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4725.1992.TB02770.X

Autoantibodies to cytokines--friends or foes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4725.1992.TB02770.X

IgG autoantibodies against interleukin 1 alpha in sera of normal individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4725.1992.TB02770.X

Auto-antibodies to tumour necrosis factor alpha in healthy humans and patients with inflammatory diseases and gram-negative bacterial infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4725.1992.TB02770.X

Autoantibodies to crude human leucocyte interferon (IFN), native human IFN, recombinant human IFN-alpha 2b and human IFN-gamma in healthy blood donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4725.1992.TB02770.X

Specific covalent binding of platelet-derived growth factor to human plasma alpha 2-macroglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4725.1992.TB02770.X

An alpha 2-macroglobulin receptor-dependent mechanism for the plasma clearance of transforming growth factor-beta 1 in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4725.1992.TB02770.X

Variations in the level of a pregnancy-associated alpha-macroglobulin in patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4725.1992.TB02770.X

Negative regulation of transforming growth factor-beta by the proteoglycan decorin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4725.1992.TB02770.X

Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4725.1992.TB02770.X

10.1111/J.1524-4725.1992.TB02770.X

21 January 2018

Identifiers

DOI

1 reference

8 August 2017

1 reference